This sensitization has been demonstrated in both in vitro studies and xenograft mouse models, where EPZ015666, in combination with the mTOR inhibitor PP242, exhibited synergistic anti-GBM effects (Fig. 5E). Here, MTOR is linked to glioblastoma.